Delivery Order SPE2DR25D1202-SPE2DR26F73CM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,920.10 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price, competitively awarded contract was issued on September 2, 2025, with a completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,331.42 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,461.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of November 25, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The vaccine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,016.78 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,074.44 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on December 10, 2025, with completion scheduled for December 11, 2025. This is a firm fixed price, non-set-aside delivery order executed through the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,954.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $6,258.56 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. The contract was competitively awarded without set-aside designation on November 13, 2025, with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is priced on a firm fixed-price basis and represents a routine...
- The Defense Logistics Agency (DLA) awarded a $3,312.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of September 8, 2025. This non-set-aside award represents a competitively awarded transaction under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,697.25 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger relationship with DLA. This delivery...
- The Defense Logistics Agency awarded a $1,080.34 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine, with performance at the company's Conshohocken, Pennsylvania location. This non-competitive, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfilled this order under its existing Indefinite Delivery...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73CMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,573.61 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on December 15, 2025, with an ultimate completion date of December 16, 2025. This non-set-aside contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The vaccine will be sourced and distributed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company's SPE2DX prime contract vehicle enables comprehensive global pharmaceutical support across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare programs. This delivery order represents a routine medical supply requirement within AmerisourceBergen's expansive federal pharmaceutical procurement portfolio, which demonstrates the company's capability to fulfill both small-value and large-scale federal medical procurement needs through competitive award processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/14/25 |